דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים: Rocket Pharmaceuticals (RCKT)

Rocket Pharmaceuticals develops innovative treatments for rare blood and heart pathologies. The year-over-year sales trend over a 12-month period demonstrates revenue dynamics, where the indicator value reaches 0.00. Demand for such services is independent of macroeconomic conditions. The brand's high authority is confirmed by successful tests. Currently, Rocket Pharmaceuticals is striving for the commercialization of drugs capable of curing severe defects in a single course.
Rocket Corp (RCKT) - פילוחי מדדים ודוחות פיננסיים

Diversifying gene therapy programs for rare pathologies allows Rocket Pharmaceuticals (RCKT) to scale revenue, which is reflected in the calculation of the trailing twelve months (TTM) sales volume relative to the same period last year. Analyzing the TTM revenue growth trajectory compared to the previous year helps identify asset overheating and assess the sustainability of the company's capitalization against changes in US Federal Reserve monetary policy.